Where Tech Meets Bio
Latest News
Nuritas, an Irish biotech company specializing in AI-powered peptide discovery from natural sources, announced it has raised $42 million in a Series C funding round. …
Read More
Alphabet's AI Spinoff Raises $300M at $5.3B Valuation Amid Biopharma Partnerships
SandboxAQ, a Palo Alto SaaS startup, operating at the intersection of artificial intelligence and quantum technology, announced it has raised over $300 million in funding, …
Read More
BioAge Labs and Novartis Ink $500M Deal to Tackle Aging-Related Diseases
BioAge Labs, a clinical-stage biopharmaceutical company developing therapies targeting the biology of aging, announced a multi-year collaboration with Novartis worth over $500 million. The partnership …
Read More
Latest News
After Raising $13M, AI-Driven Protein Biotech Appoints Board Chair
Noetik Announces Foundation Models of Spatial Biology for Precision Oncology
Bristol Myers Squibb Grants $25M for insitro’s Milestone in ALS Target Discovery
Sanofi Opens Call for Proposals for 2025 iNext Awards North America
Gameto Achieves First Live Birth Using Egg Maturation Technology Outside the Body
Gilead Sciences and Terray Therapeutics Partner to Advance AI-Driven Small Molecule Drug Discovery
Latest Insights
by Andrii Buvailo, PhD
Scientists Found a New Epigenetic Factor Preventing Inherited Diseases
Researchers at the University of Queensland have identified a crucial mechanism in mitochondrial DNA (mtDNA) that helps regulate the inheritance of disease-causing mutations. This mechanism …
Read More
by Andrii Buvailo, PhD
ThermoFace: Revealing Biological Age and Hidden Health Risks via Your Face's Heat Map
In a groundbreaking study published in Cell Metabolism in July 2024, researchers introduced "ThermoFace," a mew method that utilizes thermal facial imaging to assess biological …
Read More
FTI Survey: Healthcare & Life Sciences Optimism, M&A and AI to Drive 2025 Growth
by BiopharmaTrend
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
by Thomas Fessard
Legal and Governance Considerations in AI for Drug Discovery: New Paradigms and 2025 Outlook
by Nikhil Pradhan
The AI-driven Development Journey of ISM5411, a Potential Breakthrough Treatment for Inflammatory Bowel Disease
by Andrii Buvailo, PhD
The Importance of Accurate Patient Matching for AI Projects
by Huzaifa Ali
Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads
by Roman Kasianov
What will be the key trends in AI innovation in the Pharmaceutical Industry in 2025?
by Marina Hickson
Cautious Optimism in 2024 for Healthcare M&A
by Merlin Piscitelli
From Our Partners
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Partner Events
BIOCHINA 2025
Event Date: March 13, 2025 - March 15, 2025
Location: China (Suzhou International Expo Center)
Website: Link
Promo Code: biopharmatrend (valid till 2024-10-31)
Read more ›››
Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››
London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››
Case Studies
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Interviews
[Interview] This Vancouver-based Startup Plans To Boost Drug Design With AI
This South Korean Company is at the Forefront of AI-driven Drug Discovery
Merging AI and Quantum Computing To Boost Drug Discovery
The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández
Most Read
7 Promising RNA Biotech Companies To Watch in 2024
5 AI-Powered Companies Transforming the Future of Fertility Care
14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)
12 Notable AI-powered Biotech Companies Founded in 2021